The Joint Venture will distribute and sell certain products of Kin Fung Weisen-U, including the well-recognised gastrointestinal drug "Weisen-U" (「胃仙-U」) and the popular nasal spray brand "Flucur Nebuliser" (「呼佳噴霧劑」) to new markets in the Asia Pacific region. The Joint Venture will also explore and develop respective product line extensions for Weisen-U (「胃仙-U」) and Po Chai Pills (「保濟丸」). In particular, the Joint Venture will have the first right over Smiley and Kin Fung Weisen-U to acquire brands of gastrointestinal and respiratory drugs, and food/health supplements. For more details about Jacobson Pharma, please visit the Group's website: http://www.jacobsonpharma.comAbout Kin Fung Weisen-U Company LimitedKin Fung Weisen-U was incorporated in Hong Kong in 1960s and is principally engaged in the development of gastrointestinal and respiratory pharmaceutical drugs. Kin Fung Weisen-U is the brand owner and sole agent of Weisen-U (「胃仙-U」) in Hong Kong, Macau and the PRC.
